4.6 Article

Worsening of asthma control after COVID-19

Related references

Note: Only part of the references are listed.
Article Respiratory System

Global Initiative for Asthma Strategy 2021 Executive Summary and Rationale for Key Changes

Helen K. Reddel et al.

Summary: The GINA 2021 Strategy Report provides updated evidence-based recommendations for managing and preventing asthma, including the use of ICS-formoterol as a reliever and additional recommendations for moderate-to-severe asthma. It also introduces new treatment options for children aged 6-11. Regular personalized assessment, modifiable risk factor treatment, self-management education, and appropriate medication adjustment are highlighted as essential for optimizing asthma outcomes.

RESPIROLOGY (2022)

Article Medicine, General & Internal

Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US

Monita Karmakar et al.

Summary: This study found an association between county-level sociodemographic risk factors and COVID-19 incidence and mortality in the US. The Social Vulnerability Index was significantly correlated with both COVID-19 outcomes, suggesting that addressing social vulnerabilities and their root causes is essential to combat the disparities in the burden of the pandemic.

JAMA NETWORK OPEN (2021)

Article Allergy

Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study

Claudia Crimi et al.

Summary: This study found that nearly half of T2-SA patients have bronchiectasis, which is associated with chronic rhinosinusitis, chronic mucus hypersecretion, chronic oral corticosteroid use, and increased exacerbations. The presence of bronchiectasis is related to respiratory function, asthma control, and severity index in patients.

JOURNAL OF ASTHMA AND ALLERGY (2021)

Article Critical Care Medicine

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study

Paul Aveyard et al.

Summary: The study found that patients with certain respiratory diseases had a higher risk of hospitalization and death from COVID-19, while the risk of severe COVID-19 in asthma patients was relatively small. The use of inhaled steroids may be associated with a slightly increased risk of severe COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Article Primary Health Care

Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study

Martine Nurek et al.

Summary: In the absence of specific therapies and care pathways for long COVID, a rapid expert guide was provided through a Delphi study with primary and secondary care doctors in the UK. Thirty-three clinicians representing 14 specialties reached consensus on 35 recommendations, emphasizing the need for GPs to consider a wide range of symptoms, conduct thorough history and examination, and individualized rehabilitation for long COVID patients.

BRITISH JOURNAL OF GENERAL PRACTICE (2021)

Review Respiratory System

Asthma and COVID-19: Emphasis on Adequate Asthma Control

David D. Nassoro et al.

Summary: Asthmatics infected by respiratory viruses are at increased risk of developing exacerbations, especially if poorly controlled. Adequate asthma control is associated with decreased exacerbations. Studies show that glucocorticoids can reduce morbidity and mortality among COVID-19 patients.

CANADIAN RESPIRATORY JOURNAL (2021)

Article Critical Care Medicine

The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

Davies Adeloye et al.

Summary: An international consensus exercise was conducted to identify research priorities for understanding the long-term effects of acute COVID-19, focusing on individuals with pre-existing airways disease. High priority was given to investigations on prognostic scores at hospital admission and morbidity at 3 months and 12 months after hospital discharge, as well as comparisons of prevalence and severity of post-COVID-19 symptoms between patients with and without pre-existing airways disease.

LANCET RESPIRATORY MEDICINE (2021)

Review Allergy

Prevention and Treatment of Asthma Exacerbations in Adults

Andrew Menzies-Gow et al.

Summary: Asthma exacerbations are major contributors to disease morbidity, mainly due to viral respiratory infections and allergic sensitization. Treatment focuses on reducing airflow obstruction and suppressing inflammation, with future research directed toward antiviral activity and more encompassing regulation of underlying airway inflammation.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Respiratory System

The impact of COVID-19 on patients with asthma

Jose Luis Izquierdo et al.

Summary: The study analyzed clinical data of 71,182 asthma patients and found that those with COVID-19 were older, predominantly female, and had higher prevalence of comorbidities. The use of inhaled corticosteroids and biologics in asthma patients may have a protective effect against severe COVID-19 infection.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Allergy

Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells

Hiroki Kimura et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Allergy

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

Daniel J. Jackson et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Comparability of asthma control test scores between self and physician-administered test

Claudia Crimi et al.

RESPIRATORY MEDICINE (2020)

Editorial Material Critical Care Medicine

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

David M. G. Halpin et al.

LANCET RESPIRATORY MEDICINE (2020)

Review Public, Environmental & Occupational Health

COVID-19 and comorbidities: Deleterious impact on infected patients

Hasan Ejaz et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

Review Medicine, General & Internal

Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US

Donald J. Alcendor

JOURNAL OF CLINICAL MEDICINE (2020)

Review Respiratory System

Minimal clinically important difference for asthma endpoints: an expert consensus report

Matteo Bonini et al.

EUROPEAN RESPIRATORY REVIEW (2020)

Article Public, Environmental & Occupational Health

Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil

Leandro F. M. Rezende et al.

REVISTA DE SAUDE PUBLICA (2020)

Letter Respiratory System

Asthma in COVID-19 Hospitalizations: An Overestimated Risk Factor?

Richard Broadhurst et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)

Article Allergy

Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness

Michael R. Edwards et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Review Allergy

Assessment of Environmental Cockroach Allergen Exposure

Ginger L. Chew

CURRENT ALLERGY AND ASTHMA REPORTS (2012)

Review Microbiology

The microbiology of asthma

Michael R. Edwards et al.

NATURE REVIEWS MICROBIOLOGY (2012)

Review Respiratory System

Interpretative strategies for lung function tests

R Pellegrino et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Article Respiratory System

Standardisation of spirometry

MR Miller et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Article Allergy

Cockroach allergens and asthma

LK Arruda et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)